| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HOXB3 HHEX GSX1 KMT2D HIVEP1 ERFL NFE2 SOX30 ZBTB22 SKOR1 SHOX MECOM DMRTB1 EVX1 NR5A1 TBX20 LYL1 BHLHE40 GLIS1 NOTCH1 NPAS1 PRDM1 TBX6 | 5.13e-09 | 1412 | 81 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | HOXB3 HHEX GSX1 HIVEP1 SLC2A4RG NFE2 SOX30 ZBTB22 SKOR1 MECOM DMRTB1 ZNF683 EVX1 NR5A1 TBX20 LYL1 BHLHE40 GLIS1 NOTCH1 PRDM1 TBX6 | 2.21e-08 | 1271 | 81 | 21 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | HOXB3 HHEX GSX1 HIVEP1 SLC2A4RG NFE2 SOX30 ZBTB22 SKOR1 MECOM DMRTB1 ZNF683 EVX1 NR5A1 TBX20 LYL1 BHLHE40 GLIS1 PRDM1 TBX6 | 8.11e-08 | 1244 | 81 | 20 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | HOXB3 HHEX GSX1 HIVEP1 SLC2A4RG NFE2 SOX30 ZBTB22 SKOR1 MECOM DMRTB1 ZNF683 EVX1 NR5A1 TBX20 LYL1 BHLHE40 GLIS1 NPAS1 PRDM1 TBX6 | 2.31e-07 | 1459 | 81 | 21 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription factor binding | ZNF703 SETD1A NCOR2 HHEX LATS1 PPRC1 TLE4 NR5A1 ZFPM1 TBX20 BHLHE40 TBX6 | 4.92e-05 | 753 | 81 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 8.73e-05 | 560 | 81 | 10 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 9.53e-05 | 566 | 81 | 10 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | ZNF703 SETD1A NCOR2 HHEX LATS1 TLE4 ZFPM1 TBX20 BHLHE40 TBX6 | 1.20e-04 | 582 | 81 | 10 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.48e-04 | 562 | 81 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 4.48e-04 | 8 | 81 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 7.16e-04 | 10 | 81 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SRRT NCOR2 IGF2BP2 KMT2D ATN1 MAVS PPRC1 TLE4 FBXO7 ZFPM1 RERE DCC NOTCH1 | 7.53e-04 | 1160 | 81 | 13 | GO:0030674 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 7.55e-04 | 44 | 81 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SRRT NCOR2 IGF2BP2 KMT2D ATN1 MAVS PPRC1 TLE4 FBXO7 OTUD4 ZFPM1 RERE DCC NOTCH1 | 1.03e-03 | 1356 | 81 | 14 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.45e-03 | 303 | 81 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.52e-03 | 417 | 81 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.91e-03 | 320 | 81 | 6 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 2.10e-03 | 326 | 81 | 6 | GO:0001217 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.40e-03 | 229 | 81 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.67e-03 | 68 | 81 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.78e-03 | 69 | 81 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | protein domain specific binding | HHEX HIVEP1 KIDINS220 ATN1 MAVS NFE2 PKD1 ADGRB1 SRP68 BHLHE40 | 2.79e-03 | 875 | 81 | 10 | GO:0019904 |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.94e-03 | 20 | 81 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.00e-03 | 739 | 81 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 3.01e-03 | 71 | 81 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 3.89e-03 | 23 | 81 | 2 | GO:0071837 | |
| GeneOntologyMolecularFunction | Notch binding | 5.34e-03 | 27 | 81 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HOXB3 HHEX GSX1 KMT2D HIVEP1 MAVS PPRC1 SOX30 PKD1 SHOX MECOM EVX1 NR5A1 ZFPM1 TBX20 CCNK GLIS1 NOTCH1 TBX6 | 1.62e-06 | 1390 | 82 | 19 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF703 NCOR2 HOXB3 HHEX HIVEP1 ATN1 TLE4 SOX30 SKOR1 MECOM ZFPM1 RERE TBX20 BHLHE40 GLIS1 NOTCH1 NPAS1 PRDM1 TBX6 | 1.79e-06 | 1399 | 82 | 19 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF703 NCOR2 HOXB3 HHEX HIVEP1 ATN1 TLE4 SOX30 SKOR1 MECOM ZFPM1 RERE TBX20 BHLHE40 GLIS1 NOTCH1 NPAS1 PRDM1 TBX6 | 2.07e-06 | 1413 | 82 | 19 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NCOR2 HOXB3 HHEX HIVEP1 ATN1 TLE4 SOX30 SKOR1 ZFPM1 TBX20 BHLHE40 GLIS1 NOTCH1 NPAS1 PRDM1 TBX6 | 3.29e-06 | 1053 | 82 | 16 | GO:0000122 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOR2 HOXB3 HHEX KMT2D LATS1 KIDINS220 LATS2 NFE2 PKD1 MECOM EVX1 CCNK NOTCH1 PRDM1 TBX6 | 3.36e-06 | 929 | 82 | 15 | GO:0009792 |
| GeneOntologyBiologicalProcess | in utero embryonic development | NCOR2 HHEX KMT2D LATS1 KIDINS220 LATS2 NFE2 PKD1 MECOM CCNK NOTCH1 PRDM1 | 3.97e-06 | 596 | 82 | 12 | GO:0001701 |
| GeneOntologyBiologicalProcess | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 5.11e-06 | 29 | 82 | 4 | GO:0045736 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclin-dependent protein kinase activity | 5.88e-06 | 30 | 82 | 4 | GO:1904030 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 7.85e-06 | 338 | 82 | 9 | GO:0045165 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOR2 HOXB3 HHEX KMT2D LATS1 KIDINS220 LATS2 NFE2 PKD1 MECOM CCNK NOTCH1 PRDM1 TBX6 | 1.22e-05 | 906 | 82 | 14 | GO:0043009 |
| GeneOntologyBiologicalProcess | regulation of extrathymic T cell differentiation | 1.56e-05 | 2 | 82 | 2 | GO:0033082 | |
| GeneOntologyBiologicalProcess | heart valve formation | 3.96e-05 | 17 | 82 | 3 | GO:0003188 | |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | 4.04e-05 | 96 | 82 | 5 | GO:0000079 | |
| GeneOntologyBiologicalProcess | embryo development | NCOR2 HOXB3 HHEX KMT2D LATS1 KIDINS220 LATS2 NFE2 PKD1 MECOM EVX1 ZFPM1 TBX20 CCNK NOTCH1 PRDM1 TBX6 | 4.13e-05 | 1437 | 82 | 17 | GO:0009790 |
| GeneOntologyBiologicalProcess | inner cell mass cell fate commitment | 4.67e-05 | 3 | 82 | 2 | GO:0001827 | |
| GeneOntologyBiologicalProcess | inner cell mass cellular morphogenesis | 4.67e-05 | 3 | 82 | 2 | GO:0001828 | |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | 4.92e-05 | 100 | 82 | 5 | GO:1904029 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 1.07e-04 | 368 | 82 | 8 | GO:0030111 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 1.40e-04 | 285 | 82 | 7 | GO:0060828 | |
| GeneOntologyBiologicalProcess | mitral valve formation | 1.55e-04 | 5 | 82 | 2 | GO:0003192 | |
| GeneOntologyBiologicalProcess | extrathymic T cell differentiation | 1.55e-04 | 5 | 82 | 2 | GO:0033078 | |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 1.65e-04 | 27 | 82 | 3 | GO:0060216 | |
| GeneOntologyBiologicalProcess | pericardium development | 1.85e-04 | 28 | 82 | 3 | GO:0060039 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 2.08e-04 | 516 | 82 | 9 | GO:0016055 | |
| GeneOntologyBiologicalProcess | heart valve development | 2.65e-04 | 78 | 82 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | atrioventricular valve development | 2.76e-04 | 32 | 82 | 3 | GO:0003171 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | NCOR2 HHEX EIF4ENIF1 NFE2 HYAL3 ADGRB1 FBXO7 NR5A1 ZFPM1 DCC CCNK GLIS1 NOTCH1 TBX6 | 2.99e-04 | 1220 | 82 | 14 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of NK T cell differentiation | 3.24e-04 | 7 | 82 | 2 | GO:0051136 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 3.62e-04 | 35 | 82 | 3 | GO:0003209 | |
| GeneOntologyBiologicalProcess | gland development | 3.69e-04 | 558 | 82 | 9 | GO:0048732 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.84e-04 | 561 | 82 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | inner cell mass cell differentiation | 4.30e-04 | 8 | 82 | 2 | GO:0001826 | |
| GeneOntologyBiologicalProcess | mesenchymal cell development | 4.30e-04 | 8 | 82 | 2 | GO:0014031 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 4.40e-04 | 344 | 82 | 7 | GO:0060070 | |
| GeneOntologyBiologicalProcess | tricuspid valve development | 5.52e-04 | 9 | 82 | 2 | GO:0003175 | |
| GeneOntologyBiologicalProcess | atrioventricular valve formation | 5.52e-04 | 9 | 82 | 2 | GO:0003190 | |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 5.52e-04 | 9 | 82 | 2 | GO:0003344 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 5.72e-04 | 258 | 82 | 6 | GO:0001763 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 5.95e-04 | 362 | 82 | 7 | GO:0034504 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 6.22e-04 | 42 | 82 | 3 | GO:0003230 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 7.61e-04 | 103 | 82 | 4 | GO:0035050 | |
| GeneOntologyBiologicalProcess | nuclear transport | 7.68e-04 | 378 | 82 | 7 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 7.68e-04 | 378 | 82 | 7 | GO:0006913 | |
| GeneOntologyBiologicalProcess | heart development | 8.23e-04 | 757 | 82 | 10 | GO:0007507 | |
| GeneOntologyBiologicalProcess | central nervous system development | SETD1A NCOR2 HOXB3 HHEX GSX1 ATN1 MECOM RERE DCC TBX20 MYO16 NOTCH1 NPAS1 | 8.41e-04 | 1197 | 82 | 13 | GO:0007417 |
| GeneOntologyBiologicalProcess | nuclear export | 8.59e-04 | 185 | 82 | 5 | GO:0051168 | |
| GeneOntologyBiologicalProcess | negative regulation of protein serine/threonine kinase activity | 1.04e-03 | 112 | 82 | 4 | GO:0071901 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 1.09e-03 | 195 | 82 | 5 | GO:0030178 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 1.18e-03 | 13 | 82 | 2 | GO:0048845 | |
| GeneOntologyBiologicalProcess | regulation of cell development | SRRT SETD1A HOXB3 THPO FBXO7 ZNF683 ZFPM1 DCC BHLHE40 NOTCH1 PRDM1 TBX6 | 1.26e-03 | 1095 | 82 | 12 | GO:0060284 |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.26e-03 | 118 | 82 | 4 | GO:0001570 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.27e-03 | 412 | 82 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | spinal cord development | 1.30e-03 | 119 | 82 | 4 | GO:0021510 | |
| GeneOntologyBiologicalProcess | regulation of stem cell proliferation | 1.30e-03 | 119 | 82 | 4 | GO:0072091 | |
| GeneOntologyBiologicalProcess | cardiac chamber formation | 1.38e-03 | 14 | 82 | 2 | GO:0003207 | |
| GeneOntologyBiologicalProcess | NK T cell differentiation | 1.38e-03 | 14 | 82 | 2 | GO:0001865 | |
| GeneOntologyCellularComponent | nuclear body | SRRT CASC3 SETD1A NCOR2 HHEX HIVEP1 SLC2A4RG EIF4ENIF1 NFE2 MECOM NHS INAVA RERE BHLHE40 | 7.54e-06 | 903 | 80 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | chromatin | SETD1A NCOR2 HOXB3 HHEX GSX1 NFE2 SOX30 ZBTB22 SHOX DMRTB1 EVX1 NR5A1 ZFPM1 TBX20 LYL1 BHLHE40 NPAS1 TBX6 | 9.38e-06 | 1480 | 80 | 18 | GO:0000785 |
| MousePheno | abnormal pharyngeal arch morphology | 1.39e-05 | 171 | 65 | 7 | MP:0002884 | |
| MousePheno | abnormal vertebral articular process morphology | 2.13e-05 | 2 | 65 | 2 | MP:0004602 | |
| MousePheno | abnormal megakaryocyte morphology | 4.84e-05 | 86 | 65 | 5 | MP:0002417 | |
| MousePheno | abnormal bone marrow hematopoietic cell morphology | 1.09e-04 | 102 | 65 | 5 | MP:0013660 | |
| MousePheno | abnormal megakaryocyte physiology | 1.27e-04 | 4 | 65 | 2 | MP:0020397 | |
| MousePheno | abnormal megakaryocyte emperipolesis | 1.27e-04 | 4 | 65 | 2 | MP:0020398 | |
| MousePheno | enhanced megakaryocyte emperipolesis | 1.27e-04 | 4 | 65 | 2 | MP:0020399 | |
| MousePheno | abnormal craniofacial development | 1.44e-04 | 425 | 65 | 9 | MP:0003935 | |
| MousePheno | embryonic lethality during organogenesis | CASC3 HHEX KMT2D LATS2 PKD1 MECOM PDCD2L ZFPM1 RERE TBX20 NOTCH1 PRDM1 TBX6 | 1.64e-04 | 876 | 65 | 13 | MP:0006207 |
| Domain | HTH_motif | 1.15e-05 | 69 | 80 | 5 | IPR000047 | |
| Domain | Atrophin-like | 1.81e-05 | 2 | 80 | 2 | IPR002951 | |
| Domain | Atrophin-1 | 1.81e-05 | 2 | 80 | 2 | PF03154 | |
| Domain | LH2 | 5.90e-05 | 18 | 80 | 3 | SM00308 | |
| Domain | PLAT | 9.52e-05 | 21 | 80 | 3 | PS50095 | |
| Domain | - | 9.52e-05 | 21 | 80 | 3 | 2.60.60.20 | |
| Domain | PLAT | 9.52e-05 | 21 | 80 | 3 | PF01477 | |
| Domain | PLAT/LH2_dom | 9.52e-05 | 21 | 80 | 3 | IPR001024 | |
| Domain | REJ | 1.08e-04 | 4 | 80 | 2 | PS51111 | |
| Domain | REJ_dom | 1.08e-04 | 4 | 80 | 2 | IPR014010 | |
| Domain | PKD/REJ-like | 2.69e-04 | 6 | 80 | 2 | IPR002859 | |
| Domain | REJ | 2.69e-04 | 6 | 80 | 2 | PF02010 | |
| Domain | TF_Brachyury | 2.69e-04 | 6 | 80 | 2 | IPR002070 | |
| Domain | GPS | 4.11e-04 | 34 | 80 | 3 | SM00303 | |
| Domain | GPS | 4.49e-04 | 35 | 80 | 3 | PF01825 | |
| Domain | UBA | 4.88e-04 | 36 | 80 | 3 | PF00627 | |
| Domain | GPS | 4.88e-04 | 36 | 80 | 3 | PS50221 | |
| Domain | GPS | 5.29e-04 | 37 | 80 | 3 | IPR000203 | |
| Domain | Homeodomain-like | 5.51e-04 | 332 | 80 | 7 | IPR009057 | |
| Domain | Homeobox_metazoa | 6.03e-04 | 90 | 80 | 4 | IPR020479 | |
| Domain | SET | 7.17e-04 | 41 | 80 | 3 | PF00856 | |
| Domain | UBA | 8.83e-04 | 44 | 80 | 3 | IPR015940 | |
| Domain | BAH | 9.72e-04 | 11 | 80 | 2 | SM00439 | |
| Domain | BAH | 9.72e-04 | 11 | 80 | 2 | PF01426 | |
| Domain | BAH | 9.72e-04 | 11 | 80 | 2 | PS51038 | |
| Domain | PKD_channel | 9.72e-04 | 11 | 80 | 2 | PF08016 | |
| Domain | BAH_dom | 9.72e-04 | 11 | 80 | 2 | IPR001025 | |
| Domain | PKD1_2_channel | 9.72e-04 | 11 | 80 | 2 | IPR013122 | |
| Domain | SET | 1.01e-03 | 46 | 80 | 3 | SM00317 | |
| Domain | UBA | 1.07e-03 | 47 | 80 | 3 | PS50030 | |
| Domain | Homeobox_CS | 1.22e-03 | 186 | 80 | 5 | IPR017970 | |
| Domain | SET_dom | 1.28e-03 | 50 | 80 | 3 | IPR001214 | |
| Domain | SET | 1.28e-03 | 50 | 80 | 3 | PS50280 | |
| Domain | - | 1.35e-03 | 283 | 80 | 6 | 1.10.10.60 | |
| Domain | Post-SET_dom | 2.09e-03 | 16 | 80 | 2 | IPR003616 | |
| Domain | PostSET | 2.09e-03 | 16 | 80 | 2 | SM00508 | |
| Domain | POST_SET | 2.09e-03 | 16 | 80 | 2 | PS50868 | |
| Domain | TF_T-box | 2.36e-03 | 17 | 80 | 2 | IPR001699 | |
| Domain | TBOX | 2.36e-03 | 17 | 80 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 2.36e-03 | 17 | 80 | 2 | IPR018186 | |
| Domain | - | 2.36e-03 | 17 | 80 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 2.36e-03 | 17 | 80 | 2 | PS50252 | |
| Domain | T-box | 2.36e-03 | 17 | 80 | 2 | PF00907 | |
| Domain | TBOX_1 | 2.36e-03 | 17 | 80 | 2 | PS01283 | |
| Domain | TBOX_2 | 2.36e-03 | 17 | 80 | 2 | PS01264 | |
| Domain | UBA-like | 2.61e-03 | 64 | 80 | 3 | IPR009060 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF703 HIVEP1 SLC2A4RG ZBTB22 MECOM ZNF683 ZFPM1 GLIS1 PRDM1 | 2.83e-03 | 694 | 80 | 9 | IPR013087 |
| Domain | Homeobox | 3.32e-03 | 234 | 80 | 5 | PF00046 | |
| Domain | HOMEOBOX_1 | 3.44e-03 | 236 | 80 | 5 | PS00027 | |
| Domain | HOX | 3.50e-03 | 237 | 80 | 5 | SM00389 | |
| Domain | HOMEOBOX_2 | 3.63e-03 | 239 | 80 | 5 | PS50071 | |
| Domain | Homeobox_dom | 3.63e-03 | 239 | 80 | 5 | IPR001356 | |
| Domain | SANT_dom | 5.51e-03 | 26 | 80 | 2 | IPR017884 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF703 HIVEP1 SLC2A4RG ZBTB22 MECOM ZNF683 ZFPM1 GLIS1 PRDM1 | 5.81e-03 | 775 | 80 | 9 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF703 HIVEP1 SLC2A4RG ZBTB22 MECOM ZNF683 ZFPM1 GLIS1 PRDM1 | 5.90e-03 | 777 | 80 | 9 | PS00028 |
| Domain | SANT | 6.37e-03 | 28 | 80 | 2 | PS51293 | |
| Domain | Znf_C2H2-like | ZNF703 HIVEP1 SLC2A4RG ZBTB22 MECOM ZNF683 ZFPM1 GLIS1 PRDM1 | 6.88e-03 | 796 | 80 | 9 | IPR015880 |
| Domain | Znf_C2H2 | ZNF703 HIVEP1 SLC2A4RG ZBTB22 MECOM ZNF683 ZFPM1 GLIS1 PRDM1 | 7.39e-03 | 805 | 80 | 9 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF703 HIVEP1 SLC2A4RG ZBTB22 MECOM ZNF683 ZFPM1 GLIS1 PRDM1 | 7.56e-03 | 808 | 80 | 9 | SM00355 |
| Domain | - | 8.50e-03 | 679 | 80 | 8 | 3.30.160.60 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HOXB3 HHEX GSX1 KMT2D HIVEP1 NFE2 SOX30 SKOR1 SHOX DMRTB1 EVX1 NR5A1 ZFPM1 RERE TBX20 LYL1 BHLHE40 GLIS1 NPAS1 PRDM1 TBX6 | 2.40e-15 | 908 | 83 | 21 | 19274049 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | GSX1 NFE2 SOX30 ZBTB22 SKOR1 SHOX EVX1 NR5A1 TBX20 BHLHE40 GLIS1 PRDM1 TBX6 | 5.67e-10 | 544 | 83 | 13 | 28473536 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF703 SETD1A NCOR2 KMT2D HIVEP1 ATN1 TLE4 FBRS MECOM RERE BAHCC1 | 7.99e-10 | 351 | 83 | 11 | 38297188 |
| Pubmed | SRRT ZNF703 SETD1A NCOR2 IGF2BP2 KMT2D HIVEP1 UBAP2 ATN1 EIF4ENIF1 SMG7 TLE4 FBRS OTUD4 MECOM SRP68 RERE PRRC2A PRDM1 | 8.49e-10 | 1429 | 83 | 19 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MST1R SETD1A NCOR2 KMT2D SLC2A4RG LATS2 EIF4ENIF1 MORN1 PPRC1 PKD1 FBRS ZFPM1 NOTCH1 WNK2 ARHGAP33 BAHCC1 | 6.79e-09 | 1105 | 83 | 16 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SETD1A NCOR2 LATS1 UBAP2 ATN1 EIF4ENIF1 SPATA31E1 INAVA NOTCH1 WNK2 | 8.19e-08 | 430 | 83 | 10 | 35044719 |
| Pubmed | 8.99e-08 | 18 | 83 | 4 | 20887958 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRT NCOR2 KMT2D HIVEP1 LATS1 ATN1 TLE4 OTUD4 ZFPM1 RERE PRRC2A CCNK | 3.10e-07 | 774 | 83 | 12 | 15302935 |
| Pubmed | Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. | 4.56e-07 | 7 | 83 | 3 | 16481466 | |
| Pubmed | HIVEP1 ATN1 EIF4ENIF1 DMRTB1 RERE PRRC2A CCNK NOTCH1 WNK2 PRDM1 | 1.92e-06 | 608 | 83 | 10 | 16713569 | |
| Pubmed | Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. | 2.13e-06 | 11 | 83 | 3 | 29849151 | |
| Pubmed | 3.76e-06 | 268 | 83 | 7 | 33640491 | ||
| Pubmed | SOX9 modulates the expression of key transcription factors required for heart valve development. | 4.68e-06 | 14 | 83 | 3 | 26525672 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 5.44e-06 | 184 | 83 | 6 | 32908313 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25482410 | ||
| Pubmed | Blimp-1 Rather Than Hobit Drives the Formation of Tissue-Resident Memory CD8+ T Cells in the Lungs. | 5.63e-06 | 2 | 83 | 2 | 30899267 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30671453 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 10814707 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 38603632 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32826458 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29730476 | ||
| Pubmed | N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability. | 5.63e-06 | 2 | 83 | 2 | 23230145 | |
| Pubmed | LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function. | 5.63e-06 | 2 | 83 | 2 | 31848340 | |
| Pubmed | Expression of LATS family proteins in ovarian tumors and its significance. | 5.63e-06 | 2 | 83 | 2 | 25841306 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24026096 | ||
| Pubmed | Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer. | 5.63e-06 | 2 | 83 | 2 | 32423384 | |
| Pubmed | Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. | 5.63e-06 | 2 | 83 | 2 | 34060480 | |
| Pubmed | Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. | 5.63e-06 | 2 | 83 | 2 | 17049657 | |
| Pubmed | Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance. | 5.63e-06 | 2 | 83 | 2 | 31268774 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30692620 | ||
| Pubmed | The Hippo pathway regulates human megakaryocytic differentiation. | 5.63e-06 | 2 | 83 | 2 | 27786336 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35389518 | ||
| Pubmed | Cell type-dependent function of LATS1/2 in cancer cell growth. | 5.63e-06 | 2 | 83 | 2 | 30531839 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21317240 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28648895 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15746036 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19799973 | ||
| Pubmed | LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. | 5.63e-06 | 2 | 83 | 2 | 32015438 | |
| Pubmed | Blimp-1 induces and Hobit maintains the cytotoxic mediator granzyme B in CD8 TÂ cells. | 5.63e-06 | 2 | 83 | 2 | 30051906 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25044019 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30158530 | ||
| Pubmed | Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos. | 7.18e-06 | 16 | 83 | 3 | 15914564 | |
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 20647008 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 12431380 | ||
| Pubmed | 7.31e-06 | 418 | 83 | 8 | 34709266 | ||
| Pubmed | A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway. | 1.69e-05 | 3 | 83 | 2 | 30308519 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 27566587 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30891737 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24012335 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 19131340 | ||
| Pubmed | LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells. | 1.69e-05 | 3 | 83 | 2 | 35859006 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 34685654 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18413746 | ||
| Pubmed | Tumor suppressor LATS1 is a negative regulator of oncogene YAP. | 1.69e-05 | 3 | 83 | 2 | 18158288 | |
| Pubmed | Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. | 1.69e-05 | 21 | 83 | 3 | 10421635 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 2.47e-05 | 495 | 83 | 8 | 27705803 | |
| Pubmed | Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. | 2.90e-05 | 25 | 83 | 3 | 19786569 | |
| Pubmed | 2.90e-05 | 25 | 83 | 3 | 30912742 | ||
| Pubmed | 3.29e-05 | 152 | 83 | 5 | 38360978 | ||
| Pubmed | Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. | 3.37e-05 | 4 | 83 | 2 | 28754671 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 14966463 | ||
| Pubmed | Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. | 3.37e-05 | 4 | 83 | 2 | 21041411 | |
| Pubmed | Hippo signalling maintains ER expression and ER+ breast cancer growth. | 3.37e-05 | 4 | 83 | 2 | 33658690 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 20841485 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 32451369 | ||
| Pubmed | Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein. | 3.37e-05 | 4 | 83 | 2 | 22888005 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 29895619 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 10713164 | ||
| Pubmed | Phosphorylation of CHO1 by Lats1/2 regulates the centrosomal activation of LIMK1 during cytokinesis. | 3.37e-05 | 4 | 83 | 2 | 25786116 | |
| Pubmed | Hippo signaling instructs ectopic but not normal organ growth. | 3.37e-05 | 4 | 83 | 2 | 36395225 | |
| Pubmed | Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. | 3.37e-05 | 4 | 83 | 2 | 15343267 | |
| Pubmed | LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2/LATS1. | 3.37e-05 | 4 | 83 | 2 | 34624573 | |
| Pubmed | Inactivation of the Hippo tumor suppressor pathway promotes melanoma. | 3.37e-05 | 4 | 83 | 2 | 35768444 | |
| Pubmed | KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. | 3.37e-05 | 4 | 83 | 2 | 21233212 | |
| Pubmed | The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis. | 3.37e-05 | 4 | 83 | 2 | 21822051 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 17150957 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 34831091 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 25658096 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 25298035 | ||
| Pubmed | 3.68e-05 | 27 | 83 | 3 | 20490451 | ||
| Pubmed | 3.68e-05 | 27 | 83 | 3 | 23824573 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.79e-05 | 398 | 83 | 7 | 35016035 | |
| Pubmed | HAND2 Target Gene Regulatory Networks Control Atrioventricular Canal and Cardiac Valve Development. | 5.08e-05 | 30 | 83 | 3 | 28538179 | |
| Pubmed | 5.12e-05 | 549 | 83 | 8 | 38280479 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 24106267 | ||
| Pubmed | The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. | 5.60e-05 | 5 | 83 | 2 | 28068668 | |
| Pubmed | Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway. | 5.60e-05 | 5 | 83 | 2 | 26045165 | |
| Pubmed | The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis. | 5.60e-05 | 5 | 83 | 2 | 36229481 | |
| Pubmed | Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway. | 5.60e-05 | 5 | 83 | 2 | 32994166 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 20624913 | ||
| Pubmed | Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis. | 5.60e-05 | 5 | 83 | 2 | 35191398 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 26109051 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 29438698 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 15778499 | ||
| Pubmed | The Hippo Pathway Blocks Mammalian Retinal Müller Glial Cell Reprogramming. | 5.60e-05 | 5 | 83 | 2 | 31067451 | |
| Pubmed | Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. | 5.60e-05 | 5 | 83 | 2 | 27102484 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 31474569 | ||
| Pubmed | Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). | 5.60e-05 | 5 | 83 | 2 | 18640976 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 9724649 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 8989517 | ||
| Interaction | ALG13 interactions | ZNF703 NCOR2 IGF2BP2 KMT2D LATS1 ATN1 EIF4ENIF1 SMG7 FBRS OTUD4 DMRTB1 RERE PRRC2A CCNK | 1.68e-14 | 183 | 81 | 14 | int:ALG13 |
| Interaction | TLE3 interactions | SRRT ZNF703 NCOR2 HHEX KMT2D HIVEP1 ATN1 SMG7 TLE4 FBRS FBXO7 OTUD4 RERE TBX20 NOTCH1 PRDM1 | 1.75e-12 | 376 | 81 | 16 | int:TLE3 |
| Interaction | GSC interactions | 1.93e-12 | 87 | 81 | 10 | int:GSC | |
| Interaction | SMG7 interactions | ZNF703 NCOR2 IGF2BP2 KMT2D HIVEP1 LATS1 EIF4ENIF1 SMG7 TLE4 OTUD4 MECOM PRRC2A NPAS1 | 4.39e-10 | 319 | 81 | 13 | int:SMG7 |
| Interaction | FXR2 interactions | HIVEP1 LATS1 UBAP2 ATN1 EIF4ENIF1 SMG7 MAP3K14 ZBTB22 OTUD4 MECOM SRP68 DMRTB1 INAVA PRRC2A | 1.63e-09 | 430 | 81 | 14 | int:FXR2 |
| Interaction | TBR1 interactions | 1.74e-08 | 113 | 81 | 8 | int:TBR1 | |
| Interaction | RBM47 interactions | CASC3 IGF2BP2 HIVEP1 UBAP2 EIF4ENIF1 SMG7 OTUD4 SRP68 PRRC2A | 1.30e-07 | 204 | 81 | 9 | int:RBM47 |
| Interaction | TLE5 interactions | HHEX UBAP2 ATN1 SMG7 TLE4 MECOM DMRTB1 BHLHE40 CCNK NPAS1 PRDM1 TBX6 | 1.97e-07 | 443 | 81 | 12 | int:TLE5 |
| Interaction | RBFOX2 interactions | UBAP2 ATN1 EIF4ENIF1 FBXO7 OTUD4 MECOM SRP68 DMRTB1 RERE PRRC2A | 2.05e-07 | 284 | 81 | 10 | int:RBFOX2 |
| Interaction | TOP3B interactions | MST1R SETD1A NCOR2 IGF2BP2 KMT2D UBAP2 SLC2A4RG LATS2 EIF4ENIF1 SMG7 MORN1 PPRC1 PKD1 FBRS OTUD4 ZFPM1 PRRC2A NOTCH1 WNK2 ARHGAP33 BAHCC1 | 2.25e-07 | 1470 | 81 | 21 | int:TOP3B |
| Interaction | SP7 interactions | 3.84e-07 | 304 | 81 | 10 | int:SP7 | |
| Interaction | TBXT interactions | 4.27e-07 | 116 | 81 | 7 | int:TBXT | |
| Interaction | EGR2 interactions | 4.33e-07 | 171 | 81 | 8 | int:EGR2 | |
| Interaction | PRRC2A interactions | CASC3 IGF2BP2 UBAP2 ATN1 EIF4ENIF1 SMG7 FBXO7 OTUD4 SRP68 RERE PRRC2A | 4.35e-07 | 389 | 81 | 11 | int:PRRC2A |
| Interaction | SECISBP2 interactions | 7.12e-07 | 78 | 81 | 6 | int:SECISBP2 | |
| Interaction | KRTAP6-2 interactions | 8.54e-07 | 187 | 81 | 8 | int:KRTAP6-2 | |
| Interaction | R3HDM2 interactions | 8.77e-07 | 129 | 81 | 7 | int:R3HDM2 | |
| Interaction | R3HDM1 interactions | 1.11e-06 | 84 | 81 | 6 | int:R3HDM1 | |
| Interaction | BAG2 interactions | ZNF703 SETD1A FKBP15 UBAP2 LATS2 EIF4ENIF1 MAVS TLE4 MAP3K14 FBXO7 OTUD4 MECOM NPAS1 | 1.11e-06 | 622 | 81 | 13 | int:BAG2 |
| Interaction | PRRC2B interactions | 1.17e-06 | 265 | 81 | 9 | int:PRRC2B | |
| Interaction | GATA2 interactions | 1.36e-06 | 199 | 81 | 8 | int:GATA2 | |
| Interaction | FEV interactions | 1.58e-06 | 203 | 81 | 8 | int:FEV | |
| Interaction | PRR20B interactions | 1.66e-06 | 90 | 81 | 6 | int:PRR20B | |
| Interaction | PRR20C interactions | 1.66e-06 | 90 | 81 | 6 | int:PRR20C | |
| Interaction | PRR20D interactions | 1.66e-06 | 90 | 81 | 6 | int:PRR20D | |
| Interaction | DAZL interactions | 1.92e-06 | 145 | 81 | 7 | int:DAZL | |
| Interaction | NFIC interactions | 2.04e-06 | 210 | 81 | 8 | int:NFIC | |
| Interaction | CPEB4 interactions | 3.13e-06 | 156 | 81 | 7 | int:CPEB4 | |
| Interaction | PRR20E interactions | 3.27e-06 | 101 | 81 | 6 | int:PRR20E | |
| Interaction | PRR20A interactions | 5.09e-06 | 109 | 81 | 6 | int:PRR20A | |
| Interaction | LARP4B interactions | 5.48e-06 | 240 | 81 | 8 | int:LARP4B | |
| Interaction | TLX1 interactions | 6.69e-06 | 175 | 81 | 7 | int:TLX1 | |
| Interaction | HDAC1 interactions | SRRT NCOR2 KMT2D HIVEP1 LATS2 EIF4ENIF1 TLE4 FBRS SKOR1 MECOM ZFPM1 RERE BHLHE40 NOTCH1 BAHCC1 PRDM1 | 7.14e-06 | 1108 | 81 | 16 | int:HDAC1 |
| Interaction | CRX interactions | 8.29e-06 | 254 | 81 | 8 | int:CRX | |
| Interaction | HELZ interactions | 9.04e-06 | 257 | 81 | 8 | int:HELZ | |
| Interaction | PAX7 interactions | 1.07e-05 | 124 | 81 | 6 | int:PAX7 | |
| Interaction | PAX9 interactions | 1.40e-05 | 130 | 81 | 6 | int:PAX9 | |
| Interaction | TNRC6B interactions | 1.77e-05 | 282 | 81 | 8 | int:TNRC6B | |
| Interaction | RBMS1 interactions | 1.99e-05 | 207 | 81 | 7 | int:RBMS1 | |
| Interaction | CELF1 interactions | 2.06e-05 | 288 | 81 | 8 | int:CELF1 | |
| Interaction | MOB3A interactions | 2.21e-05 | 14 | 81 | 3 | int:MOB3A | |
| Interaction | SMG5 interactions | 2.23e-05 | 84 | 81 | 5 | int:SMG5 | |
| Interaction | TDRD3 interactions | 2.32e-05 | 212 | 81 | 7 | int:TDRD3 | |
| Interaction | USP54 interactions | 2.32e-05 | 212 | 81 | 7 | int:USP54 | |
| Interaction | CREBBP interactions | SETD1A NCOR2 HOXB3 KMT2D HIVEP1 LATS1 EIF4ENIF1 SMG7 NFE2 MECOM NR5A1 | 2.68e-05 | 599 | 81 | 11 | int:CREBBP |
| Interaction | CPEB1 interactions | 2.71e-05 | 146 | 81 | 6 | int:CPEB1 | |
| Interaction | YTHDF1 interactions | 2.89e-05 | 302 | 81 | 8 | int:YTHDF1 | |
| Interaction | MEX3B interactions | 3.12e-05 | 222 | 81 | 7 | int:MEX3B | |
| Interaction | SAV1 interactions | 3.27e-05 | 151 | 81 | 6 | int:SAV1 | |
| Interaction | FOXI1 interactions | 3.46e-05 | 92 | 81 | 5 | int:FOXI1 | |
| Interaction | YTHDF2 interactions | 3.64e-05 | 312 | 81 | 8 | int:YTHDF2 | |
| Interaction | ZNF608 interactions | 3.65e-05 | 93 | 81 | 5 | int:ZNF608 | |
| Interaction | OTUD4 interactions | 4.60e-05 | 236 | 81 | 7 | int:OTUD4 | |
| Interaction | FMR1 interactions | CASC3 NCOR2 IGF2BP2 UBAP2 EIF4ENIF1 SMG7 TLE4 OTUD4 INAVA PRRC2A | 5.62e-05 | 536 | 81 | 10 | int:FMR1 |
| Interaction | YTHDF3 interactions | 5.98e-05 | 246 | 81 | 7 | int:YTHDF3 | |
| Interaction | CEP85 interactions | 6.14e-05 | 169 | 81 | 6 | int:CEP85 | |
| Interaction | GATA1 interactions | 6.55e-05 | 171 | 81 | 6 | int:GATA1 | |
| Interaction | TAF1 interactions | 8.46e-05 | 260 | 81 | 7 | int:TAF1 | |
| Interaction | PAX8 interactions | 8.50e-05 | 111 | 81 | 5 | int:PAX8 | |
| Interaction | KRTAP19-7 interactions | 1.09e-04 | 117 | 81 | 5 | int:KRTAP19-7 | |
| Interaction | SMAP2 interactions | 1.14e-04 | 189 | 81 | 6 | int:SMAP2 | |
| Interaction | PHIP interactions | 1.43e-04 | 197 | 81 | 6 | int:PHIP | |
| Interaction | PUM1 interactions | 1.56e-04 | 287 | 81 | 7 | int:PUM1 | |
| Interaction | TLX3 interactions | 1.70e-04 | 291 | 81 | 7 | int:TLX3 | |
| Interaction | TENT5B interactions | 1.72e-04 | 69 | 81 | 4 | int:TENT5B | |
| Interaction | MAGED1 interactions | 1.85e-04 | 295 | 81 | 7 | int:MAGED1 | |
| Interaction | CXXC1 interactions | 1.92e-04 | 132 | 81 | 5 | int:CXXC1 | |
| Interaction | NUP43 interactions | SRRT ZNF703 SETD1A NCOR2 KMT2D HIVEP1 ATN1 EIF4ENIF1 MAVS RERE | 1.98e-04 | 625 | 81 | 10 | int:NUP43 |
| Interaction | EIF4ENIF1 interactions | 2.05e-04 | 300 | 81 | 7 | int:EIF4ENIF1 | |
| Interaction | TLE1 interactions | 2.18e-04 | 213 | 81 | 6 | int:TLE1 | |
| Interaction | ZC3H7A interactions | 2.29e-04 | 215 | 81 | 6 | int:ZC3H7A | |
| Interaction | SETD1B interactions | 2.37e-04 | 75 | 81 | 4 | int:SETD1B | |
| Interaction | CHST15 interactions | 2.59e-04 | 31 | 81 | 3 | int:CHST15 | |
| Interaction | ATXN2 interactions | 2.60e-04 | 312 | 81 | 7 | int:ATXN2 | |
| Interaction | CRABP2 interactions | 2.76e-04 | 78 | 81 | 4 | int:CRABP2 | |
| Interaction | ERG interactions | 2.79e-04 | 223 | 81 | 6 | int:ERG | |
| Interaction | WWTR1 interactions | 2.93e-04 | 422 | 81 | 8 | int:WWTR1 | |
| Interaction | ANKRD17 interactions | 3.00e-04 | 226 | 81 | 6 | int:ANKRD17 | |
| Interaction | NUP35 interactions | 3.02e-04 | 424 | 81 | 8 | int:NUP35 | |
| Interaction | KLF3 interactions | 3.14e-04 | 228 | 81 | 6 | int:KLF3 | |
| Interaction | RUNX1 interactions | 3.27e-04 | 324 | 81 | 7 | int:RUNX1 | |
| Interaction | SOX7 interactions | 3.34e-04 | 82 | 81 | 4 | int:SOX7 | |
| Interaction | KLF8 interactions | 3.58e-04 | 329 | 81 | 7 | int:KLF8 | |
| Interaction | KDM1A interactions | NCOR2 KMT2D HIVEP1 EIF4ENIF1 SMG7 TLE4 FBRS MECOM ZFPM1 RERE NOTCH1 PRDM1 | 3.62e-04 | 941 | 81 | 12 | int:KDM1A |
| Interaction | TENT5A interactions | 3.66e-04 | 84 | 81 | 4 | int:TENT5A | |
| Interaction | PRDM1 interactions | 3.66e-04 | 84 | 81 | 4 | int:PRDM1 | |
| Interaction | PAX2 interactions | 3.83e-04 | 85 | 81 | 4 | int:PAX2 | |
| Interaction | IRF4 interactions | 3.83e-04 | 85 | 81 | 4 | int:IRF4 | |
| Interaction | FXR1 interactions | NCOR2 HIVEP1 UBAP2 ATN1 EIF4ENIF1 SMG7 OTUD4 INAVA BHLHE40 PRRC2A | 3.84e-04 | 679 | 81 | 10 | int:FXR1 |
| Interaction | STXBP4 interactions | 4.00e-04 | 86 | 81 | 4 | int:STXBP4 | |
| Interaction | SOX6 interactions | 4.28e-04 | 157 | 81 | 5 | int:SOX6 | |
| Interaction | RBPMS interactions | 4.36e-04 | 340 | 81 | 7 | int:RBPMS | |
| Interaction | PRMT2 interactions | 4.96e-04 | 91 | 81 | 4 | int:PRMT2 | |
| Interaction | SOX10 interactions | 5.17e-04 | 92 | 81 | 4 | int:SOX10 | |
| Interaction | C6orf141 interactions | 5.17e-04 | 92 | 81 | 4 | int:C6orf141 | |
| Interaction | HCFC2 interactions | 5.17e-04 | 92 | 81 | 4 | int:HCFC2 | |
| Interaction | TLE4 interactions | 5.17e-04 | 92 | 81 | 4 | int:TLE4 | |
| Interaction | RBFOX1 interactions | 5.17e-04 | 92 | 81 | 4 | int:RBFOX1 | |
| Interaction | CNOT6L interactions | 5.39e-04 | 93 | 81 | 4 | int:CNOT6L | |
| Interaction | RERE interactions | 5.39e-04 | 93 | 81 | 4 | int:RERE | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.26e-04 | 34 | 52 | 3 | 487 | |
| GeneFamily | HOXL subclass homeoboxes | 4.49e-04 | 52 | 52 | 3 | 518 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.07e-03 | 17 | 52 | 2 | 1197 | |
| GeneFamily | T-boxes | 1.21e-03 | 18 | 52 | 2 | 766 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.33e-03 | 25 | 52 | 2 | 775 | |
| GeneFamily | Basic helix-loop-helix proteins | 3.90e-03 | 110 | 52 | 3 | 420 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.27e-03 | 718 | 52 | 7 | 28 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.19e-03 | 41 | 52 | 2 | 1298 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.02e-02 | 53 | 52 | 2 | 532 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 9.99e-06 | 338 | 81 | 8 | M17094 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 186 | 83 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 189 | 83 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.49e-06 | 140 | 83 | 5 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-05 | 173 | 83 | 5 | 34357f0e22c4b6d84582492c82c1ea733ca8477d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 175 | 83 | 5 | 9a96794df049d8228fea57c1584c160191d36b56 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.44e-05 | 90 | 83 | 4 | 3817a5b0235e632d976ea565175bdbebbd959bf0 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.44e-05 | 90 | 83 | 4 | a0baaf2b3cf07d457f0d242fc213689cba6fd449 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.44e-05 | 90 | 83 | 4 | a528f5dcee1a356dea89ff2588d2e0f276f2d5fc | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.44e-05 | 90 | 83 | 4 | ab4b08c6ac8695b38f841c0ecf2bb2c032111d04 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-05 | 185 | 83 | 5 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.62e-05 | 187 | 83 | 5 | 29b2e2be26a9d72b154760e47acf61cfe2f45fa7 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.05e-05 | 193 | 83 | 5 | 643f992dbce639e7d147924d8b8f455fcebf215a | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|World / Lineage, cell class and subclass | 3.13e-05 | 194 | 83 | 5 | f054d78429364622d402ce1d9bf6ad13a1a1bf7e | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.29e-05 | 196 | 83 | 5 | b826dce5b3daa8eb3d4a530b9564de58d9ce3767 | |
| Drug | Sulfabenzamide [127-71-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 5.51e-07 | 199 | 81 | 8 | 6634_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A | 5.77e-06 | 193 | 81 | 7 | 4067_DN | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 7.82e-06 | 2 | 83 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | SETD1A IGF2BP2 PPRC1 NFE2 FBXO7 OTUD4 NR5A1 ZFPM1 LYL1 MYO16 TBX6 | 1.47e-05 | 799 | 83 | 11 | EFO_0010701 |
| Disease | Cerebral Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C0334583 | |
| Disease | Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C0280785 | |
| Disease | Grade I Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 4.72e-05 | 25 | 83 | 3 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 4.72e-05 | 25 | 83 | 3 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 5.32e-05 | 26 | 83 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 5.32e-05 | 26 | 83 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 5.32e-05 | 26 | 83 | 3 | C0334582 | |
| Disease | Anaplastic astrocytoma | 5.98e-05 | 27 | 83 | 3 | C0334579 | |
| Disease | Lymphoid leukemia | 2.16e-04 | 8 | 83 | 2 | C0023448 | |
| Disease | benign neoplasm (implicated_via_orthology) | 2.16e-04 | 8 | 83 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | household income | 2.21e-04 | 304 | 83 | 6 | EFO_0009695 | |
| Disease | mean corpuscular hemoglobin concentration | KRBA1 SLC2A4RG ATN1 MORN1 NFE2 FBXO7 OTUD4 MECOM ZFPM1 MYO16 TBX6 | 2.65e-04 | 1105 | 83 | 11 | EFO_0004528 |
| Disease | nicotine use | 2.78e-04 | 9 | 83 | 2 | EFO_0005430 | |
| Disease | platelet crit | 3.37e-04 | 952 | 83 | 10 | EFO_0007985 | |
| Disease | forced expiratory volume | SETD1A SYNDIG1L NCOR2 HOXB3 IGF2BP2 SLC2A4RG OTUD4 MECOM DCC | 3.75e-04 | 789 | 83 | 9 | EFO_0004314 |
| Disease | kidney cancer (implicated_via_orthology) | 4.23e-04 | 11 | 83 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | intracranial aneurysm (is_implicated_in) | 5.07e-04 | 12 | 83 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Connective Tissue Diseases | 5.98e-04 | 13 | 83 | 2 | C0009782 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 6.96e-04 | 14 | 83 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | eosinophil count | NCOR2 HHEX HIVEP1 NFE2 MAP3K14 SLC35E1 ZFPM1 RERE MYO16 NOTCH1 BAHCC1 TBX6 | 9.07e-04 | 1488 | 83 | 12 | EFO_0004842 |
| Disease | bipolar disorder, sex interaction measurement | 1.16e-03 | 18 | 83 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | noggin measurement | 1.16e-03 | 18 | 83 | 2 | EFO_0021995 | |
| Disease | feeling miserable measurement | 1.45e-03 | 79 | 83 | 3 | EFO_0009598 | |
| Disease | Glioblastoma | 1.45e-03 | 79 | 83 | 3 | C0017636 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 1.48e-03 | 295 | 83 | 5 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | Ovarian Failure, Premature | 1.59e-03 | 21 | 83 | 2 | C0085215 | |
| Disease | Giant Cell Glioblastoma | 1.74e-03 | 84 | 83 | 3 | C0334588 | |
| Disease | Splenomegaly | 1.74e-03 | 22 | 83 | 2 | C0038002 | |
| Disease | balding measurement | 1.74e-03 | 792 | 83 | 8 | EFO_0007825 | |
| Disease | colorectal cancer, hormone replacement therapy | 1.98e-03 | 88 | 83 | 3 | EFO_0003961, MONDO_0005575 | |
| Disease | congenital heart disease (is_implicated_in) | 2.07e-03 | 24 | 83 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | beta-aminoisobutyric acid measurement | 2.07e-03 | 24 | 83 | 2 | EFO_0010464 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLPPSLYPPHFYPNP | 241 | A0A1W2PQ73 | |
| PKLGRPLPSPSYVHP | 2266 | Q9P281 | |
| IHYPLPLPYQGKPDP | 131 | Q9Y6R9 | |
| SPRYPGGPLPDFPNH | 1291 | O14514 | |
| PHQPPFCLPFYLIPP | 316 | O14503 | |
| AGGLPYPFPSHLPLP | 266 | P49640 | |
| LSQGPARPYHPPPLF | 151 | P54259 | |
| FQAPPGAPPPHPQLY | 206 | P54259 | |
| LGSLRPYPPGPAHLP | 536 | P54259 | |
| LPPAYGPPAHLPYHP | 461 | O75909 | |
| PFLGPVPIAPPFFPH | 846 | Q01804 | |
| LPPGFYPHIHTPPLG | 401 | Q96N11 | |
| PGPALPEAFYPPLGL | 561 | Q99742 | |
| FPGLFPSGLYHRPPL | 491 | Q03112 | |
| LLGPPPPGYHPFLFL | 371 | Q5T089 | |
| DPSAFSYAPPGHPLP | 1071 | Q9Y618 | |
| GYPHPQFTLRPVPFP | 1271 | P43146 | |
| GLAYPPLPLHEGPPR | 1076 | Q9ULH0 | |
| PLPLHEGPPRAPSGY | 1081 | Q9ULH0 | |
| PGYLLTPPPHPDLGA | 311 | A5PL33 | |
| PHGYLSDVASPPLLP | 2206 | P46531 | |
| RPGPPTPAAAHSIPY | 116 | Q7Z434 | |
| NYQGPPPPYPKHLLH | 551 | O95835 | |
| GLAFPPPAAGLYVPH | 301 | Q9NRM7 | |
| GPPPAPYRPCAHLAF | 1581 | Q9Y6X6 | |
| PLYAPTPLLQPAHPT | 16 | Q03014 | |
| NPPIFPLGPYHATVP | 146 | Q86UP0 | |
| PSGLLAHAFPPGPNY | 181 | P45452 | |
| PGDSPRIHLPLNYPP | 946 | Q08174 | |
| HPVPPGLPLFLPYYI | 176 | Q9BRP1 | |
| PLYPAPLSQPPHFQG | 486 | Q5T1M5 | |
| LYELHAAGAPPPPPP | 746 | Q8IX07 | |
| EQPHGLYLLPPGAPF | 306 | Q8N2G8 | |
| PPLFPYAVPPPHALH | 26 | Q9H4S2 | |
| GPRGAPPAAPYHPFT | 386 | Q9Y6M1 | |
| YNELLPPAFHLPLPG | 31 | Q9Y4U1 | |
| PPAFHLPLPGPTLAF | 36 | Q9Y4U1 | |
| VAPLPGHLLGPDPYA | 1896 | Q7Z442 | |
| PPLHRSPDFLLSYPP | 1126 | O14559 | |
| AHPLLYSRLAPPPPP | 401 | Q9HAH7 | |
| HPHQTPAPLPNPGLY | 586 | O15234 | |
| FPGTPYPEPSKLPHT | 61 | I3L273 | |
| PGYLSALHFLPPPPP | 286 | Q96MA1 | |
| TIPFYPNPLHPRPFP | 421 | Q9Y3I1 | |
| LFPSIYLPPRLPPAH | 241 | O43820 | |
| PLPPPAGPSLYGLNH | 361 | P14651 | |
| PGLPSYVHIPSYRPP | 151 | O75342 | |
| PHPFLNSVYIGPAGP | 106 | P12980 | |
| LFGPHQQGLPPPYPL | 156 | Q8NBF1 | |
| SYAPGLPPPHPTTKA | 611 | P54792 | |
| HHPKLLLPPGYFPAG | 506 | Q3KP66 | |
| YPHVSPSGYPCLPPP | 926 | Q5VV67 | |
| PALDSYFHPPGTPAP | 761 | Q8NAC3 | |
| PAPGHPGPRAPYLSA | 731 | P98161 | |
| GRPVTFYPHPLPSPG | 1141 | P98161 | |
| QDGGPLPLPTHPFPY | 246 | Q99558 | |
| HPDSGFPLPPPPYEL | 71 | Q16621 | |
| PAHLHGPYPYPETPP | 16 | A6NDD5 | |
| QKLPPPLFPHPYGFP | 386 | P84550 | |
| PDYVLPPSLHGPEPK | 136 | Q13285 | |
| LSIAAPPLPAYPPAH | 256 | Q6T4R5 | |
| FIPIHHPGAFPPLPS | 646 | Q92540 | |
| LDFYPPGVHPSGLVP | 741 | P48634 | |
| LHPYRSQPLYLPPGP | 1871 | P48634 | |
| HLAAHAPYLMFPPPP | 231 | O15266 | |
| LLLLYVHSDPPSPPP | 81 | Q6ZUB1 | |
| LGSYPGYAPLPHLPP | 386 | O75626 | |
| GYAPLPHLPPAFIPS | 391 | O75626 | |
| ARFPYPPGTLPNPLL | 1466 | Q9P2R6 | |
| HPSSGPLLPPRFYPR | 96 | Q96K37 | |
| VLLPPSSPGPPHRVY | 916 | E7EW31 | |
| PYLASLPLGYPPHQP | 616 | O15047 | |
| LPLGYPPHQPAYLLP | 621 | O15047 | |
| HFPPGFQPIPCKPLF | 576 | Q9UHB9 | |
| VYQPPPLGHPATLFG | 591 | O94993 | |
| ILPPGLTPGLPYPHQ | 776 | Q9BXP5 | |
| GQPFYPLPAASHPLL | 871 | Q9NRA8 | |
| APGYAPPPFLHILPA | 1056 | Q5T6F2 | |
| VSPYKPGHSVFPLPP | 296 | Q9H7S9 | |
| PSPPLPPEAAHFLFG | 171 | Q9NR83 | |
| VPCPYPTPFGIVPHA | 366 | Q04727 | |
| PGPALSPSVPLHYLP | 241 | Q7L0R7 | |
| SGYPAAPPAVPFAPH | 396 | O95947 | |
| PFAPHFLQGGPFPLP | 406 | O95947 | |
| ATPIPHPIQGSLPPY | 376 | Q9UMR3 | |
| PPHLPPYLAPASQVG | 756 | Q9Y3S1 | |
| GFTLPGFRFLPPPHP | 851 | Q04912 | |
| GYSAVPANIIPPPHP | 846 | P15822 | |
| SYAPSHPPRPLLPLD | 406 | O15209 | |
| AFYPGYPLLLPPPHL | 191 | Q8IZ20 | |
| PTHPPTGQYTLFPLP | 296 | P40225 | |
| LPPPAPDGSLPYLSH | 2616 | O14686 |